Brian R White1, Lindsay S Rogers1, Matthew P Kirschen2,3. 1. Division of Pediatric Cardiology, Department of Pediatrics. 2. Department of Anesthesiology and Critical Care Medicine. 3. Department of Neurology, The Children's Hospital of Philadelphia, Perelman School of Medicine, University of Pennsylvania, Philadelphia, Pennsylvania, USA.
Abstract
PURPOSE OF REVIEW: Patients with congenital heart disease (CHD) suffer from a pattern of neurodevelopmental abnormalities including deficits in language and executive function. In this review, we summarize recent studies that examine these outcomes, their risk factors, possible biomarkers, and attempts to develop therapeutic interventions. RECENT FINDINGS: The latest literature has highlighted the role of genetics in determining neurologic prognosis, as we have increased our understanding of potentially modifiable perioperative risk factors. The role of potentially neurotoxic medical therapies has become more salient. One recent focus has been how neurodevelopment affects quality of life and leads to a high prevalence of mental illness. Neuroimaging advances have provided new insights into the pathogenesis of deficits. SUMMARY: Although many risk factors in CHD are not modifiable, there is promise for interventions to improve neurodevelopmental outcomes in patients with CHD. Biomarkers are needed to better understand the timing and prognosis of injury and to direct therapy. Research into psychosocial interventions is urgently needed to benefit the many survivors with CHD.
PURPOSE OF REVIEW: Patients with congenital heart disease (CHD) suffer from a pattern of neurodevelopmental abnormalities including deficits in language and executive function. In this review, we summarize recent studies that examine these outcomes, their risk factors, possible biomarkers, and attempts to develop therapeutic interventions. RECENT FINDINGS: The latest literature has highlighted the role of genetics in determining neurologic prognosis, as we have increased our understanding of potentially modifiable perioperative risk factors. The role of potentially neurotoxic medical therapies has become more salient. One recent focus has been how neurodevelopment affects quality of life and leads to a high prevalence of mental illness. Neuroimaging advances have provided new insights into the pathogenesis of deficits. SUMMARY: Although many risk factors in CHD are not modifiable, there is promise for interventions to improve neurodevelopmental outcomes in patients with CHD. Biomarkers are needed to better understand the timing and prognosis of injury and to direct therapy. Research into psychosocial interventions is urgently needed to benefit the many survivors with CHD.
Authors: Kendall M Lawrence; Patrick E McGovern; Ali Mejaddam; Avery C Rossidis; Heron Baumgarten; Aimee Kim; Judith B Grinspan; Daniel J Licht; Ryne A Didier; Arastoo Vossough; Enrico Radaelli; Jack Rychik; Limei Song; William H Peranteau; Marcus G Davey; Alan W Flake; J William Gaynor Journal: J Thorac Cardiovasc Surg Date: 2019-01-11 Impact factor: 5.209
Authors: Eric M Graham; Renee' H Martin; Andrew M Atz; Kasey Hamlin-Smith; Minoo N Kavarana; Scott M Bradley; Bahaaldin Alsoufi; William T Mahle; Allen D Everett Journal: J Thorac Cardiovasc Surg Date: 2019-01-23 Impact factor: 5.209
Authors: Eméfah C Loccoh; Sunkyung Yu; Janet Donohue; Ray Lowery; Jennifer Butcher; Sara K Pasquali; Caren S Goldberg; Karen Uzark Journal: Cardiol Young Date: 2018-01-23 Impact factor: 1.093
Authors: Miranda J Campbell; Jenny M Ziviani; Christian F Stocker; Asaduzzaman Khan; Leanne Sakzewski Journal: Cardiol Young Date: 2018-10-24 Impact factor: 1.093
Authors: Mary R Becky Gregory; Paula M Prouhet; Cynthia L Russell; Brenda R Pfannenstiel Journal: J Cardiovasc Nurs Date: 2018 Jul/Aug Impact factor: 2.083
Authors: Christopher J Kelly; Daan Christiaens; Dafnis Batalle; Antonios Makropoulos; Lucilio Cordero-Grande; Johannes K Steinweg; Jonathan O'Muircheartaigh; Hammad Khan; Geraint Lee; Suresh Victor; Daniel C Alexander; Hui Zhang; John Simpson; Joseph V Hajnal; A David Edwards; Mary A Rutherford; Serena J Counsell Journal: J Am Heart Assoc Date: 2019-03-05 Impact factor: 5.501
Authors: Jonah A Padawer-Curry; Lindsay E Volk; Constantine D Mavroudis; Tiffany S Ko; Vincent C Morano; David R Busch; Tami M Rosenthal; Richard W Melchior; Brandon C Shade; Kellie L Schiavo; Timothy W Boorady; Alexander L Schmidt; Kristen N Andersen; Jake S Breimann; Jharna Jahnavi; Kobina G Mensah-Brown; Arjun G Yodh; Christopher E Mascio; Todd J Kilbaugh; Daniel J Licht; Brian R White; Wesley B Baker Journal: Pediatr Res Date: 2021-05-04 Impact factor: 3.953